Biotech

All Articles

Sanofi flunks MS study, giving another blow to Denali contract

.Sanofi has actually stopped a period 2 trial of Denali Therapeutics-partnered oditrasertib in multi...

Turnstone lays off 60%, shakes up C-suite to extend money

.Turnstone Biologics is lessening its own headcount by 60% and also shocking its own C-suite so as t...

Gilead gives up on $15M MASH bet after reviewing preclinical data

.In a year that has actually seen an authorization as well as a raft of readouts for metabolic dysfu...

Texas biotech centers cancer pact, pins wishes on weight problems

.Alaunos Rehabs is actually axing an agreement along with Precigen, losing hope licensing civil righ...

Capricor allotments even more information for DMD therapy after launching BLA

.Capricor Therapeutics is actually taking a triumph lap for their stage 2 Duchenne muscle dystrophy ...

FDA spots Kezar lupus trial in hold adhering to 4 client fatalities

.The FDA has put Kezar Life Sciences' lupus test on hold after the biotech warned four deaths in the...

Phase 3 Academic Rock trial attacks SMA objective, sending out stockpile 200%

.A phase 3 trial of Scholar Rock's vertebral muscular degeneration (SMA) applicant has hit its key e...

CAMP 4 is newest to eye IPO, while Upstream define $182M plan

.RNA biotech CAMP4 Rehabs has actually marked out think about a $67 thousand IPO, with inflammation-...

Galecto buys leukemia medicine, loses bone tissue cancer possession in pivot

.A year after the breakdown of an idiopathic lung fibrosis prospect sent Galecto on a seek salvation...

Judo tosses down $100M to knock senseless kidney ailment

.Taking the floor covering is actually Judo Biography, an ambitious biotech equipped with $one hundr...